Electra Therapeutics
Drug DiscoveryWebsite
Operator of a biotechnology company intended for the treatment of immunological diseases and cancer. The company's lead product is a monoclonal antibody that targets a signal regulatory protein on the...
Valuation
$479M
Market implied
Share Price
N/A
Total Raised
$301M
Last Round
Later Stage VC (Series C)
Oct 2025
Latest Funding Round
Later Stage VC (Series C)
Oct 22, 2025
$183M
raised
Investors
+14 other investors